International Normalized Ratio
"International Normalized Ratio" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
System established by the World Health Organization and the International Committee on Thrombosis and Hemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardized using the International Sensitivity Index for the particular test reagent/instrument combination used.
| Descriptor ID |
D019934
|
| MeSH Number(s) |
E01.370.225.625.115.320 E05.200.625.115.320
|
| Concept/Terms |
International Normalized Ratio- International Normalized Ratio
- International Normalized Ratios
- Normalized Ratio, International
- Normalized Ratios, International
- Ratio, International Normalized
- Ratios, International Normalized
- INR
|
Below are MeSH descriptors whose meaning is more general than "International Normalized Ratio".
Below are MeSH descriptors whose meaning is more specific than "International Normalized Ratio".
This graph shows the total number of publications written about "International Normalized Ratio" by people in this website by year, and whether "International Normalized Ratio" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2014 | 2 | 1 | 3 |
| 2015 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "International Normalized Ratio" by people in Profiles.
-
Clinical outcomes after 4F-PCC for warfarin-associated ICH and baseline GCS less than or equal to 8. Am J Emerg Med. 2022 09; 59:59-62.
-
Institution of prothrombin complex concentrate protocols is associated with a reduction in plasma administration at a Tertiary Care Hospital. J Clin Anesth. 2021 Jun; 70:110164.
-
Emergent Warfarin Reversal With Fixed-Dose 4-Factor Prothrombin Complex Concentrate. Ann Pharmacother. 2020 11; 54(11):1090-1095.
-
A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic. Thromb Res. 2020 08; 192:73-74.
-
Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate. Thromb Haemost. 2020 Feb; 120(2):207-215.
-
Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial. JAMA. 2019 09 03; 322(9):834-842.
-
Clotting-Factor Concentrations 5 Days After Discontinuation of Warfarin. Reg Anesth Pain Med. 2018 Aug; 43(6):616-620.
-
A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. PLoS One. 2018; 13(8):e0196908.
-
Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial. JAMA. 2017 09 26; 318(12):1115-1124.
-
Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation. J Stroke Cerebrovasc Dis. 2018 Jan; 27(1):192-197.